Open Access Open Access  Restricted Access Subscription or Fee Access

Current guidelines for Covid-19 and people living with HIV/AIDS-A Review

Sonia Arora

Abstract


There is an extraordinary worry about the effect of COVID-19 (Corona virus disease-2019) among the almost 40 million people living with HIV (PLWH) around the world. Having HIV (Human immune deficiency virus) doesn’t present assurance against serious appearances of COVID-19. A few drug trials/investigations looking at antiretroviral drugs against HIV to treat SARS-CoV-2 have shown no mortality advantage. Subsequently, there is no sign to change antiretroviral treatment (ART) regimens among virologically stifled PLWH to forestall COVID-19. HIV care services have been unfavorably affected in a few nations during this pandemic yet has set out a freedom for speeding up successful techniques like dispensing multi-month ART. Decentralizing HIV care in low-asset settings and fusing telemedicine in high-asset settings will be basic in moderating stuns to medical care frameworks later on.


Full Text:

PDF

References


National Center for Immunization and Respiratory Diseases (NCIRD). (2021, Feb) Division of

Viral Diseases, What to Know About HIV and COVID-19. [Online] Available from

https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/hiv.html

HIV.gov. (2021,Feb) Guidance for COVID-19 and People with HIV. [Online] Available from

https://clinicalinfo.hiv.gov/en/guidelines/COVID-19-and-persons-hiv-interim-guidance/interimguidance-COVID-19-and-persons-hiv.html

Dotters-Katz S, Hughes BL.(2020) Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal

Medicine Subspecialists Need to Know. [Online] Available from

https://s3.amazonaws.com/cdn.smfm.org/media/2267/COVID19-_updated_3-17-20_PDF.pdf.

Liu Y, Chen H, et al. Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection

during pregnancy. J Infect. 2020; S0163-4453(20)30109-2.

Chen H, Guo J, et al. Clinical characteristics and intrauterine vertical transmission potential of

COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet.

; 395(10226):809-815.

Siston AM, Rasmussen SA, et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant

women in the United States. JAMA. 2010;303(15):1517-1525.

Alfaraj SH, Al-Tawfiq JA, et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol

Infect. 2019;52(3):501-503.

Wong SF, Chow KM, et al. Pregnancy and perinatal outcomes of women with severe acute

respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-297.

Wang D, Hu B, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel

Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.

Wang S, Guo L, Chen L, et al. A Case Report of Neonatal 2019 Coronavirus Disease in China.

Clin. Infect Dis. 2020; 71(15):853-857.

Dong Y, Mo X, et al. Epidemiology of COVID-19 among Children in China. Pediatrics.

;145(6):20200702.

Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease.

Pediatrics. 2020;145(6):20200834.

Shen K, Yang Y, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in

children: experts' consensus statement. World J Pediatr. 2020;16(3):223-231.

Ogimi C, Englund JA, et al. Characteristics and outcomes of coronavirus infection in children: The

role of viral factors and an immunocompromised state. J Pediatric Infect Dis Soc. 2019; 8(1):21-

UNAIDS | (2020) What people living with HIV need to know about HIV and COVID-19. [online]

Available from https://www.unaids.org/sites/default/files/media_asset/HIV_COVID19_brochure_en.pdf


Refbacks

  • There are currently no refbacks.